Sorrento Therapeutics Inc (SRNE) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Sorrento Therapeutics Inc.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 4 | $35 | $21 | $28 | $7.58 | 269.39% |
The Trend in the Analyst Price Target
Over the past 84 days, SRNE's average price target has gone up $2.5.
Over the past 297 days, SRNE's average upside potential has been 201.12%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2020-06-10 | 2 | 24 | 24 | 24.00 | 4.540 | 428.63% |
| 2020-07-30 | 2 | 30 | 24 | 27.00 | 8.550 | 215.79% |
| 2020-08-25 | 2 | 30 | 21 | 25.50 | 8.225 | 210.03% |
| 2020-10-13 | 2 | 30 | 21 | 25.50 | 11.950 | 113.39% |
| 2020-11-08 | 1 | 21 | 21 | 21.00 | 6.980 | 200.86% |
| 2020-11-28 | 2 | 30 | 21 | 25.50 | 8.150 | 212.88% |
| 2020-12-07 | 2 | 30 | 21 | 25.50 | 7.690 | 231.6% |
| 2020-12-09 | 2 | 30 | 21 | 25.50 | 8.210 | 210.6% |
| 2020-12-19 | 2 | 30 | 21 | 25.50 | 7.350 | 246.94% |
| 2020-12-26 | 2 | 30 | 21 | 25.50 | 7.890 | 223.19% |
| 2021-01-02 | 2 | 30 | 21 | 25.50 | 6.825 | 273.63% |
| 2021-01-09 | 2 | 30 | 21 | 25.50 | 7.440 | 242.74% |
| 2021-01-16 | 2 | 30 | 21 | 25.50 | 9.500 | 168.42% |
| 2021-01-23 | 3 | 35 | 21 | 28.67 | 9.640 | 197.41% |
| 2021-01-30 | 4 | 35 | 21 | 28.00 | 12.660 | 121.17% |
| 2021-02-06 | 4 | 35 | 21 | 28.00 | 13.960 | 100.57% |
| 2021-02-13 | 4 | 35 | 21 | 28.00 | 14.390 | 94.58% |
| 2021-02-20 | 4 | 35 | 21 | 28.00 | 13.150 | 112.93% |
| 2021-02-27 | 4 | 35 | 21 | 28.00 | 9.670 | 189.56% |
| 2021-03-06 | 4 | 35 | 21 | 28.00 | 8.880 | 215.32% |
| 2021-03-13 | 4 | 35 | 21 | 28.00 | 10.250 | 173.17% |
| 2021-03-20 | 4 | 35 | 21 | 28.00 | 9.560 | 192.89% |
| 2021-04-03 | 4 | 35 | 21 | 28.00 | 8.010 | 249.56% |
SRNE Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.5 | 0 | 4 | 0 | 0 | 0 | 4 |
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- SRNE has a greater upside potential (average analyst target price relative to current price) than 95.62% of all US stocks.
- The number of analysts covering the stock of SRNE is higher than 20.15% of stocks in the mid market cap category.
- The variance in analysts' estimates of SRNE is lower than 25.19% of all US stocks.
- SRNE has a higher average analyst price target than 35.6% of stocks in the mid market cap category.
In the Pharmaceutical Products industry, CNSP, CBIO and MNOV are the three stocks most similar to Sorrento Therapeutics Inc regarding the price target and analyst recommendation information presented here.
Is SRNE a Buy, Hold or Sell? See the POWR Ratings now!